glp-1 agonist clinical trials Outcomes with Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled | Drugs GLP-1 Agonists Weight Loss Drugs
Description
This occurred 2 months after initiating weekly semaglutide injections for weight loss
NauckMAMeierJJCavenderMAEl AzizMADruckerDJ
Medication Adherence in the Real World In controlled trials, participants are closely monitored and encouraged to stay on their medication regimen
A 2025 study in the American Journal of Ophthalmology did not find a significant increase in NAION or ischemic optic neuropathy risk in patients taking semaglutide or GLP-1 medications compared with diabetes or high-BMI control groups
Complications of type 2 diabetes
Exenatide twice daily: a review of its use in the management of patients with type 2 diabetes mellitus
